The parent company for Southern California compounder Mesa Pharmacy informed the U.S. Securities and Exchange Commission that it was not able to file its financial statement for the second quarter of 2016.
Praxsyn Corp. said in its Tuesday filing that it was “not able to complete timely its financial statements without unreasonable effort or expense. The company cited the same reason in previous filings, saying it was unable to file its first quarter 2016 and 2015 annual report on time.
Greg Sundem, chairman and chief executive officer of Praxsyn, said in a June 21 lette...
Comments